CDSCO Cosmetic Registration in India: Complete 2026 Guide for Luxury Cosmetic Imports

 

Regulatory Compliance Summary: Under Rule 12(1) of the Cosmetics Rules, 2020, no cosmetic product can be imported into India unless it is covered by an Import Registration Certificate granted by the Central Licensing Authority (CLA) under the Central Drugs Standard Control Organisation (CDSCO). The registration application is submitted online in Form COS-1 via the SUGAM portal by an eligible Indian entity (an authorised agent, subsidiary, or importer) or the foreign manufacturer. Upon satisfactory evaluation of safety, quality, ingredient compliance with Indian Standards (IS 4707), and Chapter VI labelling rules, CDSCO grants the Import Registration Certificate in Form COS-2. Form COS-2 remains valid perpetually, provided a retention fee is paid every five years. The statutory fee is USD 1,000 per product category, USD 500 per manufacturing site, and USD 50 per shade or variant. Import consignments arriving at Indian ports without a valid COS-2 endorsement are subject to immediate detention, rejection, or re-export.

CDSCO Cosmetic Registration at a Glance

Regulatory Parameter	Official Detail / Statutory Specification	Legal Reference
Regulatory Authority	Central Licensing Authority (CLA), Central Drugs Standard Control Organisation (CDSCO), Director General of Health Services, Ministry of Health and Family Welfare, Government of India.	Section 3(aaa), Drugs & Cosmetics Act, 1940
Application Form	Form COS-1 (Submitted digitally via SUGAM portal).	Rule 12(1), Cosmetics Rules, 2020
Registration Certificate	Form COS-2 (Import Registration Certificate).	Rule 13, Cosmetics Rules, 2020
Digital Portal	CDSCO SUGAM Online Portal (cdscoonline.gov.in).	Official CDSCO Digital Workflow
New Cosmetic Pathway	Form COS-12 (Application for prior permission) $\rightarrow$ Form COS-3 (Permission granted).	Chapter V, Rule 32, Cosmetics Rules, 2020
Subsequent Importer Pathway	Form COS-4 (Application) $\rightarrow$ Form COS-4A (Import Registration Number).	Rule 14, Cosmetics Rules, 2020
Certificate Validity	Perpetual, subject to payment of the retention fee every 5 years from the date of issue.	Rule 15, Cosmetics Rules, 2020
Primary Legislation	Cosmetics Rules, 2020 (G.S.R. 768(E)) read with Drugs and Cosmetics Act, 1940.	Ministry of Health & Family Welfare

Who Needs CDSCO Cosmetic Registration in India?

Any entity intending to introduce foreign-manufactured cosmetics into the Indian market must ensure the products are registered under Form COS-2 before shipping. Under Rule 12(2) of the Cosmetics Rules, 2020, the application in Form COS-1 can be filed by:

1. The Foreign Manufacturer Direct: Overseas brand owners who establish a registered office in India or appoint a local representative.

2. An Authorised Agent in India: An Indian legal entity formally appointed by the foreign manufacturer via an executed Power of Attorney (PoA) to act on their behalf for regulatory filings.

3. An Indian Subsidiary of the Foreign Manufacturer: A legally incorporated Indian entity belonging to the same corporate group.

4. An Authorized Indian Importer: An Indian business holding a valid Import Export Code (IEC) that has been specifically authorised by the overseas manufacturer to apply for registration.

What Is Cosmetic Under Indian Law?

Section 3(aaa) of the Drugs and Cosmetics Act, 1940 defines a cosmetic as:

"Any article intended to be rubbed, poured, sprinkled or sprayed on, or introduced into, or otherwise applied to, the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, and includes any article intended for use as a component of cosmetic."

The Cosmetic vs. Drug vs. New Cosmetic Classification Spectrum

Understanding product classification is critical to prevent regulatory rejection or customs seizure.

• Standard Cosmetic: Formulations intended solely for external epidermal, hair, nail, lip, or oral cavity application for cleansing, scenting, or beautifying (e.g., hydrating creams, lipsticks, eau de parfum).

• New Cosmetic: Defined under Rule 3(r) as a cosmetic containing a novel ingredient not previously used in India or not recognized for cosmetic use in standard national or international literature. Requires prior approval in Form COS-3 via filing Form COS-12 before filing Form COS-1.

• Drug / Quasi-Drug: Formulations that claim to alter physiological functions, cure diseases, treat medical skin conditions (e.g., severe acne, eczema), or are administered invasively (e.g., injectable skin boosters, microneedling serums designed to penetrate the dermis). Injectables are strictly barred from the cosmetic classification in India.

Is “Luxury Cosmetic” a Separate Regulatory Category?

No. From a strict regulatory standpoint, the CDSCO does not recognize "luxury," "prestige," "niche," or "clean beauty" as distinct legal classifications.

A $500 botanical face cream from a luxury French house and a $5 mass-market moisturiser are evaluated under the exact same statutory framework: the Cosmetics Rules, 2020 and applicable BIS safety standards.

However, luxury imports face unique commercial-regulatory hurdles:

• Complex Formulations & Exotic Extracts: High-end skincare often utilizes proprietary peptides, fermentation lysates, or rare botanical extracts that may trigger "New Cosmetic" scrutiny under Rule 3(r) if safety literature is lacking.

• Aesthetic Packaging Constraints: Luxury brands rely heavily on bespoke glass jars, minimalist typography, and unmarred outer boxes. Indian Chapter VI labelling mandates require specific legal text (importer details, COS-2 number, ingredient lists), necessitating elegant over-stickering solutions to avoid brand dilution.

• Multi-Site Sourcing: Premium beauty conglomerates frequently manufacture different product lines across multiple international facilities (e.g., skincare in Switzerland, fragrances in France, makeup in Italy). Each facility requires an individual site registration fee under the Third Schedule.

Regulatory Framework for Imported Cosmetics in India

Cosmetic imports operate under an interconnected web of statutory regulations and national safety standards:

1. The Drugs and Cosmetics Act, 1940: Primary enabling legislation regulating the import, manufacture, distribution, and sale of drugs and cosmetics in India.

2. The Cosmetics Rules, 2020: Codified safety, licensing, import registration, and labelling standards dedicated exclusively to cosmetics (replacing earlier provisions under the Drugs and Cosmetics Rules, 1945).

3. Bureau of Indian Standards (BIS):

• Ninth Schedule Compliance: Products must conform to the quality standards published by BIS under the Ninth Schedule of the Cosmetics Rules, 2020.

• IS 4707 (Part 1): List of raw materials, dyes, colors, and pigments prohibited for use in cosmetics.

• IS 4707 (Part 2): List of restricted raw materials and permitted preservatives, UV filters, and colorants with maximum allowed concentrations.

• IS 4011: Methods of safety evaluation for cosmetics (dermatological and toxicological safety testing protocols).

4. Customs Act, 1962 & DGFT Policy: Authorizes Central Customs authorities at Indian Ports of Entry to inspect, verify, and draw samples from imported cosmetic consignments to confirm valid COS-2 certification prior to bill-of-entry clearance.

Step-by-Step CDSCO Cosmetic Registration Process

Step 1: Product Regulatory & Category Assessment

Map every SKU, shade, and fragrance variant precisely to the Fourth Schedule of the Cosmetics Rules, 2020 (which codifies over 80 distinct cosmetic categories). Incorrect category mapping leads to fee miscalculations and portal query rejections.

Step 2: Establish Applicant Structure

Appoint an Authorised Agent in India via an official Power of Attorney (PoA) or utilize an Indian subsidiary/authorised importer holding a valid IEC.

Step 3: Ingredient & Safety Standards Review

Screen all INCI ingredient lists against IS 4707 (Parts 1 & 2). Ensure heavy metals (Lead, Arsenic, Mercury), banned preservatives, or unapproved colorants are completely absent. Confirm active levels fall within statutory limits.

Step 4: Overseas Document Collection & Legalisation

Obtain authenticated manufacturing licenses, Good Manufacturing Practice (GMP / ISO 22716) certificates, and Free Sale Certificates (FSC) from the country of origin. Documents must be duly notarised and apostilled (or authenticated by the Indian Embassy/Consulate in non-Hague member nations).

Step 5: Indian Applicant Documentation

Prepare the local regulatory file, including the Power of Attorney (First Schedule format), Indian importer incorporation documents, wholesale drug/cosmetic sales license (if applicable), and IEC registration.

Step 6: Label and Packaging Compliance

Draft compliant artwork for inner and outer packaging incorporating all mandatory Chapter VI declarations and allocating designated space for Indian over-labelling/stickering.

Step 7: SUGAM Online Portal Filing & Fee Payment

Create an enterprise account on the CDSCO SUGAM portal (cdscoonline.gov.in). Complete the online Form COS-1 application, upload all vectorized PDF annexures, and pay the non-refundable statutory fees via Bharatkosh in equivalent USD/INR.

Step 8: CDSCO Scrutiny & Query Resolution

The Central Licensing Authority evaluates the dossier. If discrepancies, insufficient toxicological data, or labelling defects are identified, CDSCO issues an official offline or online query letter. The applicant must file a formal, point-by-point clarification response within the stipulated window.

Step 9: COS-2 Issuance & Post-Registration Compliance

Upon satisfactory review, the CLA grants the Import Registration Certificate in Form COS-2. The registration number must be affixed onto all commercial imports before customs clearance.

Documents Required for Form COS-1

All foreign documentation must be valid, legible, and apostilled/consularised.

Document Title	Document Source	Primary Regulatory Purpose	Statutory Status
Power of Attorney (PoA)	Foreign Manufacturer	Authorises the Indian agent/importer to file Form COS-1 and represent the brand. Must follow the layout in the First Schedule.	Mandatory
Free Sale Certificate (FSC)	National Regulatory Authority (e.g., US FDA, French ANSM, UK MHRA)	Proves the product is freely sold to consumers in the country of origin.	Mandatory
Manufacturing License / Operation Approval	State/National Health Authority	Demonstrates that the manufacturing facility operates under official legal authorization.	Mandatory
GMP Certificate / ISO 22716	Authorized Auditing Body / Government Authority	Validates quality control standards at the manufacturing plant.	Mandatory
Qualitative-Quantitative Formulation	Foreign Manufacturer's R&D / Regulatory Team	Lists all INCI ingredients with exact percentage composition, CAS numbers, and function.	Mandatory
Product Testing Specifications & COA	Manufacturer Quality Control Lab	Certificate of Analysis (COA) proving physical, chemical, and microbiological testing against BIS parameters.	Mandatory
Original Outer & Inner Labels	Manufacturer Packaging Team	Validates artwork against Chapter VI mandatory declaration rules.	Mandatory
Non-Animal Testing Declaration	Foreign Manufacturer	Certification that the finished cosmetic and its ingredients were not tested on animals after November 12, 2014.	Mandatory
Heavy Metal & Microbiological Test Reports	ISO 17025 Accredited Lab	Confirms heavy metal impurities (Pb, As, Hg) and microbial loads meet Indian limits.	Mandatory
Form COS-3 Approval Certificate	CDSCO Central Licensing Authority	Prior safety approval for novel ingredients.	Conditional (Only for New Cosmetics)

Indian Cosmetic Labelling Requirements & Luxury Packaging Solutions

Under Chapter VI (Rules 33–37) of the Cosmetics Rules, 2020, all cosmetics sold in India must display specific statutory information.

Mandatory Label Declarations

MANDATORY LABEL ELEMENTS

1. Brand & Product Name

2. Fourth Schedule Category & Function Statement

3. Net Contents (Metric units: ml, g)

4. Full INCI Ingredient List (Descending order of weight)

5. Name & Complete Address of Overseas Manufacturer

6. Name & Complete Address of Authorized Indian Importer

7. Import Registration Certificate No: "RC/COS-xxxxxx"

8. Batch / Lot Number

9. Manufacturing Date & Expiry Date ("Use Before MM/YY")

10. Country of Origin Statement ("Made in France")

11. Special Storage Conditions & Safety Warnings

Preserving Luxury Brand Aesthetics: Compliant Over-Labelling

Luxury beauty houses often express concern over sticking large white labels over embossed velvet boxes or metallic compacts.

Legal Over-Labelling Framework:

• Rule 33 allows mandatory import-specific details—specifically the Importer Name/Address and the Import Registration Certificate Number (COS-2)—to be affixed via an indelible supplementary label (sticker) after clearance or at bonded customs warehouses prior to commercial market distribution.

• Best Practice for Luxury Packaging: Utilize clear, high-grade transparent polymer stickers with metallic foil or color-matched typography that integrate into the brand's aesthetic without obstructing batch codes, warnings, or primary product branding.

What Is a “New Cosmetic”? (Form COS-12 & COS-3 Pathway)

If a product formulation incorporates an ingredient that has never been used in India or is unlisted in standard cosmetic literature (e.g., IS 4707, US CIR, EU CosIng), it triggers the New Cosmetic regulatory pathway under Chapter V, Rule 32.

STEP 1: FORM COS-12 FILING

Submit safety & toxicological data + USD 500 fee to CLA

Evaluation of Toxicological Profile

STEP 2: FORM COS-3 APPROVAL

Central Licensing Authority issues prior marketing permission

Pre-requisite Granted

STEP 3: FORM COS-1 FILING

Submit standard import application enclosing Form COS-3 certificate

• Application Form COS-12: Filed offline with the CLA accompanied by safety, toxicological, dermatological, and global usage data.

• Statutory Fee: USD 500 (or equivalent INR).

• Approval Form COS-3: Upon proving ingredient safety, CDSCO grants permission in Form COS-3. This document must be attached to the subsequent Form COS-1 filing.

Importing Already-Registered Cosmetics (Form COS-4 & COS-4A)

Where a foreign manufacturer has already secured a valid Form COS-2 registration through an existing Authorised Agent or subsidiary, another Indian importer wishing to import the exact same products from the same manufacturer is not required to submit a fresh Form COS-1.

Under Rule 14, the secondary importer files an application in Form COS-4. Upon verification that the underlying product, site, and manufacturer registrations remain active under Form COS-2, the CLA issues an Import Registration Number in Form COS-4A to the secondary importer.

Do FDA Approval, CE Marking, or ISO 22716 Replace CDSCO Registration?

No. A common misconception among international brands entering India is assuming that US FDA clearance, European CE marking, or ISO 22716 certification exempts them from CDSCO oversight.

While these certifications establish international quality credibility and satisfy prerequisite documentary requirements during COS-1 filing (such as proving GMP compliance), they carry zero statutory force for market entry on their own. Every imported cosmetic SKU must independently obtain a Form COS-2 certificate issued by the Indian Central Licensing Authority prior to crossing customs.

Statutory Fee Structure & Cost Breakdown

The fee structure for cosmetic import registration is governed by the Third Schedule of the Cosmetics Rules, 2020. All government fees are payable via Bharatkosh in equivalent Indian Rupees (INR) or US Dollars (USD).

Official Government Fee Schedule

Fee Head	Statutory Amount (USD)	Remarks / Application Scope
Category Registration Fee	USD 1,000 per category	Covers one category listed in the Fourth Schedule (e.g., Face Creams).
Manufacturing Site Fee	USD 500 per site	Charged for each individual manufacturing facility listed in the registration.
Variant / Shade Fee	USD 50 per variant	Applies to each additional shade, color, or fragrance variant under a registered category.
New Cosmetic Permission (COS-12)	USD 500 per application	Non-refundable fee for prior novel ingredient evaluation.
5-Year Retention Fee	USD 1,000 (Category) + USD 500 (Site)	Due every 5 years to maintain certificate validity perpetually.

Ancillary Operational Expenses

In addition to direct government fees, importers must budget for ancillary operational cost heads:

• Legalisation & Apostille Charges: Document notary, apostille, or consular authentication fees charged by country-of-origin state departments.

• Laboratory Testing: ISO 17025 accredited laboratory fees for heavy metals, microbial limit tests, and stability testing.

• Customs Duty & Bonded Warehousing: Port storage and over-labelling charges at Indian ports of entry.

Realistic Timelines: Regulatory vs. Operational

Promotional claims promising "CDSCO approval in 14 days" are misleading. Importers must account for both operational document preparation and statutory government review cycles.

1. Document Collection, Apostille & Testing - 30 – 60 Days

2. SUGAM Dossier Compilation & Filing - 7 – 14 Days

3. CDSCO Technical Scrutiny Cycle - 60 – 90 Working Days

4. Query Resolution Buffer (Applicant Side) - 15 – 30 Days

5. Final COS-2 Grant & Endorsement - 15 – 30 Days

TOTAL REALISTIC TIMELINE - 4 to 6 Months

Statutory Note: Under the Cosmetics Rules, 2020, the official target processing time for the Central Licensing Authority is up to 180 working days from the date of complete application submission.

Why CDSCO Cosmetic Applications Get Delayed or Rejected

TOP CDSCO FILING PITFALLS

1. Invalid Apostille / Missing Embassy Consularization

2. Ingredient Discrepancies between FSC, COA, and SUGAM Portal

3. Inclusion of Banned Substances under IS 4707 (e.g., Heavy Metals)

4. Improper Fourth Schedule Category Mapping

5. Therapeutic Claims on Packaging (e.g., "Cures Eczema")

Delay Trigger	Root Cause	Preventive Action
Mismatched Formulation Data	Ingredient percentages differ between the qualitative-quantitative formula, FSC, and label.	Conduct a strict 3-way document audit prior to portal upload.
Un-Apostilled FSC	Submitting a Free Sale Certificate issued by a trade association rather than a recognized National Regulatory Body, or omitting an apostille.	Ensure FSC is issued by an official government body (e.g., US FDA, ANSM) and duly apostilled.
Borderline Drug Claims	Packaging artwork contains therapeutic phrasing (e.g., "clinically treats psoriasis," "stimulates dermal repair").	Remove medical claims; restrict language purely to beautification, moisturizing, or cleansing.
Category Misclassification	Mapping a multi-purpose product to a single category, causing fee shortfall queries.	Map every secondary claim against the Fourth Schedule prior to paying fees.

Luxury Cosmetic Import Scenarios

1. High-End French Skincare Line (Multi-Site Sourcing)

• Scenario: A Paris luxury brand imports anti-aging creams produced at two distinct facilities in France and Switzerland.

• Strategy: The applicant files a single Form COS-1 under the "Skincare" category ($1,000 category fee). However, because two separate manufacturing locations are involved, two site fees ($500 x 2 = $1,000) are assessed. Total government site/category fee: $2,000.

2. Premium Niche Fragrance Collection

• Scenario: An artisanal perfume brand launches 1 base fragrance with 12 scent variations utilizing the exact same carrier base.

• Strategy: The base fragrance is registered under the Fourth Schedule "Fragrance/Perfume" category ($1,000). The remaining 11 fragrance variations qualify as variants under the same category ($50 x 11 = $550).

3. Korean/Japanese Beauty (K-Beauty / J-Beauty Active Extracts)

• Scenario: A Seoul skincare brand imports a serum featuring a novel fermented botanical extract not recognized in IS 4707 or international cosmetic literature.

• Strategy: The brand cannot file Form COS-1 directly. It must first submit Form COS-12 accompanied by clinical safety/toxicological data. Once Form COS-3 approval is granted by the CLA, the product proceeds to standard Form COS-1 registration.

Pre-Filing Compliance Checklist

Before initiating filing on the CDSCO SUGAM portal, confirm that your dossier satisfies all regulatory criteria:

• Applicant Eligibility: Authorized Indian Agent or Subsidiary possesses a valid IEC and valid corporate credentials.

• Power of Attorney: Executed strictly as per the First Schedule format, signed by the foreign manufacturer, and duly apostilled/consularised.

• Free Sale Certificate: Issued by the National Competent Authority in the country of origin, listing all proposed SKUs and variants, and duly apostilled.

• IS 4707 Audit: All ingredients checked against IS 4707 (Part 1 & Part 2) to confirm no prohibited or restricted substances exceed permissible limits.

• Non-Animal Testing Certification: Self-declaration issued by the overseas manufacturer confirming no post-2014 animal testing.

• Laboratory CoA: Certificates of Analysis proving heavy metals (Lead, Arsenic, Mercury) and microbiological limits comply with Indian Standards.

• Chapter VI Label Proofs: Inner and outer artwork drafted with dedicated area reserved for Indian over-labelling/stickering.

Post-Registration Compliance & Retention

Obtaining Form COS-2 is an ongoing regulatory obligation, not a one-time event.

• 5-Year Retention Fee: Form COS-2 remains valid perpetually, provided the registration holder pays the statutory retention fee ($1,000 category / $500 site) before the expiry of each 5-year block.

• 15-Day Change Notification: Any change in formulation, product composition, testing specification, or artwork labeling must be reported to CDSCO within 15 days, accompanied by an undertaking of continued compliance with BIS standards.

• 180-Day Ownership Constitution Change: If the corporate structure of the foreign manufacturer or Indian registration holder changes (e.g., merger, acquisition, buy-out), a fresh application must be submitted within 180 days.

2026 CDSCO Regulatory Watch

Enforcement Against Therapeutic & Injectable Claims

CDSCO issued explicit directives reinforcing that cosmetic products cannot be administered via injections and cannot make medical or therapeutic claims. Products marketed with terms such as "skin boosters," "injectable glow," "dermal repair," or "clinical cure for pigmentation" face heightened scrutiny, potential registration cancellation, or border rejections if they imply drug-like activity without holding a valid drug approval.

Digital Communication & Influencer Marketing Vetting

CDSCO enforcement extends beyond physical product labels to include digital marketing, official brand websites, and promotional campaigns in India. Foreign brands entering India must ensure their localized marketing claims remain strictly within beautifying and cleansing definitions.

Worked Compliance Examples

Example 1: Standard Foreign Skincare Product

• Product: Hydrating Hyaluronic Face Cream (Manufactured in Italy).

• Status: All ingredients listed in IS 4707 Part 2. Free Sale Certificate obtained from Italian Ministry of Health (duly apostilled).

• Regulatory Route: Standard Form COS-1 filing via SUGAM portal.

• Outcome: CDSCO grants Form COS-2 Import Registration Certificate.

Example 2: Product Containing a Novel Active Ingredient

• Product: Brightening Serum containing a novel marine peptide not documented in IS 4707 or international safety literature.

• Regulatory Route: Form COS-12 application filed offline with safety and toxicological dossier. Upon evaluation, CDSCO issues Form COS-3 permission. Brand then submits Form COS-1 attaching the COS-3 certificate.

• Outcome: Product obtains Form COS-2 clearance following novel ingredient pre-approval.

Common CDSCO Cosmetic Registration Mistakes

1. Filing FSCs Issued by Trade Associations: CDSCO rejects Free Sale Certificates issued by commercial chambers of commerce; they must originate from a recognized government health authority.

2. Omitting Apostille/Legalisation: Unauthenticated foreign documents are summarily rejected during scrutiny.

3. Assuming US FDA Approval is Sufficient: Believing overseas approvals override Indian statutory requirements without obtaining Form COS-2.

4. Mismatched Product Names: Minor spelling differences between the FSC, Power of Attorney, and SUGAM portal entries trigger formal query holds.

5. Using Unapproved Dyes/Colorants: Formulating with shade pigments not listed under permitted IS 4707 schedules.

6. Making Anti-Aging Medical Claims: Using language that promises physiological alterations rather than superficial aesthetic improvements.

7. Ignoring Heavy Metal Limits: Failing to supply ISO 17025 accredited laboratory test reports verifying Lead, Arsenic, and Mercury compliance.

8. Incorrect Shade Category Mapping: Treating distinctly different functional formulations as mere shade variants to save statutory fees.

9. Failing to Report Packaging Changes: Modifying labels post-registration without submitting the mandatory 15-day notification to CDSCO.

10. Delaying Retention Fee Payment: Missing the 5-year retention fee deadline, causing the Import Registration Certificate to lapse.

Frequently Asked Questions (FAQs)

1. Is CDSCO registration mandatory for importing luxury cosmetics into India?

Yes. Rule 12(1) of the Cosmetics Rules, 2020 mandates that all cosmetic products imported into India must be registered under Form COS-2 before commercial import.

2. What is the difference between Form COS-1 and Form COS-2?

Form COS-1 is the online application submitted by the applicant via SUGAM. Form COS-2 is the official Import Registration Certificate issued by CDSCO upon approval.

3. How long does the CDSCO cosmetic registration process take?

The statutory review timeline is up to 180 working days. Overall operational timelines, including document apostille and query resolution, typically range between 4 to 6 months.

4. What is the validity period of a Form COS-2 certificate?

Form COS-2 remains valid perpetually, provided the 5-year retention fee is paid prior to the end of each 5-year block.

5. Can a foreign brand apply for CDSCO registration without an Indian office?

Yes, by appointing an Authorised Agent in India via an executed and apostilled Power of Attorney (PoA).

6. What is a "New Cosmetic" under Indian law?

A cosmetic that contains an ingredient that has not been used previously in India or is not recognized in standard cosmetic literature under Rule 3(r). It requires prior approval in Form COS-3 via filing Form COS-12.

7. What are the government fees for registering cosmetics in India?

USD 1,000 per product category, USD 500 per manufacturing site, and USD 50 per shade/variant under the Third Schedule.

8. Can imported luxury cosmetics be over-labelled in India?

Yes. Chapter VI allows mandatory import declarations (Importer name/address and COS-2 number) to be applied via indelible secondary stickers after import or in customs bonded warehouses.

9. What happens if an ingredient is not listed in IS 4707?

If the ingredient is unlisted and novel, the applicant must follow the New Cosmetic pathway (Form COS-12) to prove safety before submitting Form COS-1.

10. Can multiple importers bring in the same foreign cosmetic brand?

Yes. Secondary importers can apply via Form COS-4 to receive an Import Registration Number under Form COS-4A, referencing the existing valid Form COS-2.

11. Does ISO 22716 or US FDA clearance grant automatic import approval?

No. International certifications fulfill supporting quality requirements but do not replace the statutory requirement for CDSCO Form COS-2 registration.

12. Are animal testing declarations required for cosmetic imports?

Yes. India strictly prohibits the import of cosmetics tested on animals. Importers must submit a self-declaration from the manufacturer confirming compliance.

Practical Regulatory Advisory

Navigating the CDSCO regulatory ecosystem requires precise classification, strict ingredient screening against IS 4707, and rigorous packaging compliance. If you require an evaluation to determine whether your imported cosmetics follow the standard COS-1 route, the secondary COS-4 route, or the novel ingredient COS-12 pathway, conducting a product-level technical audit prior to SUGAM portal submission helps prevent unnecessary query holds and fee forfeitures.